The Role of Skin Microbiota in Hepatic or Renal Pruritus
NCT05604469 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2022-11-03
Summary
* Various neurotransmitters may share in the pathogenesis of hepatic and renal itching.
* Skin microbiota may share in the pathogenesis of pruritus.
Conditions
- Renal Failure
- Hepatic Failure
- Pruritus
Interventions
- DIAGNOSTIC_TEST
-
Isolation of skin microbiota
Isolation of skin microbiota including, Staphylococcus epidermidis, Propionibacterium acnes, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus pyogenes and Candida.
Sponsors & Collaborators
-
Zagazig University
lead OTHER_GOV
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-10-01
- Primary Completion
- 2023-04-01
- Completion
- 2023-06-01
Countries
- Egypt
Study Locations
More Related Trials
-
Identification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic Inflammatory Skin Diseases
NCT06599411 ·Status: NOT_YET_RECRUITING
-
Validation of a Questionnaire to Identify Signs and Symptoms of Nephrogenic Systemic Fibrosis
NCT00869479 ·Status: COMPLETED
-
Evaluation and Treatment of Patients With Dermatologic Diseases
NCT00001506 ·Status: COMPLETED
-
Vulvar Mucosal Specialty Clinic Chart Review
NCT02881229 ·Status: TERMINATED
-
The Acquisition of Blood and Skin Samples From Normal Volunteers to Support Research Activities on Dermatologic Diseases
NCT00001505 ·Status: COMPLETED
-
Role of Macrophage Migratory Inhibitory Factor in Systemic Sclerosis
NCT03268330 ·Status: UNKNOWN
-
Studies of Patients With Skin Disease, Patients With Neurological Degenerations, and Normal Volunteers
NCT00001164 ·Status: COMPLETED
-
A Protocol Based Treatment for Debilitating Fibrosing Skin Disorders With (Anti-CD 20), Rituximab, Evaluating Safety and Efficacy
NCT00936546 ·Status: COMPLETED ·Phase: PHASE2
-
Human Leukocyte Antigen Class II (DRB1 and DQB1) Alleles and Haplotypes Frequencies in Patients With Pemphigus Vulgaris Among the Russian Population
NCT05284929 ·Status: UNKNOWN
-
NADPH Oxidase Correction in mRNA-transfected Granulocyte-enriched Cells in Chronic Granulomatous Disease (CGD)
NCT05189925 ·Status: RECRUITING ·Phase: PHASE1
-
Gene Polymorphism in Tinea Versicolor
NCT04769804 ·Status: UNKNOWN
-
Histochemical Study of Vitiligo in Sohag University Hospital Patients
NCT05869942 ·Status: UNKNOWN ·Phase: NA
-
Genetic Architecture of Neutrophil-Mediated Inflammatory Skin Diseases
NCT05732987 ·Status: RECRUITING
-
Physiopathological Study and Pharmacological Modulation of Cutaneous Atrophy's Markers Induced by Glucocorticoids
NCT00709579 ·Status: UNKNOWN ·Phase: PHASE3
-
Sensory Symptoms in Active Vitiligo
NCT05390164 ·Status: UNKNOWN
-
Cutaneous Manifestations of Coronavirus Disease 2019(COVID-19).
NCT05094687 ·Status: COMPLETED
-
Swiss Itch Registry
NCT06120907 ·Status: RECRUITING
-
Vulvar Scarring Grading Scale for Lichen Sclerosus
NCT02880904 ·Status: TERMINATED
-
The Gut and Skin Microbiome in Vitiligo Disease Progression
NCT03577327 ·Status: RECRUITING
-
Research in Skin Inflammation
NCT00026741 ·Status: COMPLETED
-
Pathophysiological Study of the Sensitive Scalp
NCT07156422 ·Status: RECRUITING ·Phase: NA
-
Metabolic Profiling of Immune Responses in Immune-mediated Diseases
NCT04864886 ·Status: RECRUITING
-
Identifying Skin Biopsy Sites
NCT01632644 ·Status: COMPLETED
-
Study of Scaling Disorders and Other Inherited Skin Diseases
NCT00001292 ·Status: COMPLETED
-
N-Acetyl Cysteine in Pathologic Skin Picking
NCT01063348 ·Status: COMPLETED ·Phase: PHASE2